Hyungsuk Kim
Hyungsuk Kim
Associate Professor, Kwangwoon University, Seoul, Korea
Verified email at
Cited by
Cited by
Heart disease and stroke statistics—2014 update: a report from the American Heart Association
AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, MJ Blaha, S Dai, ...
circulation 129 (3), e28-e292, 2014
First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer
BJ Solomon, T Mok, DW Kim, YL Wu, K Nakagawa, T Mekhail, E Felip, ...
New England Journal of Medicine 371 (23), 2167-2177, 2014
Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a …
H Wilke, K Muro, E Van Cutsem, SC Oh, G Bodoky, Y Shimada, ...
The lancet oncology 15 (11), 1224-1235, 2014
Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung Cancer
S Peters, DR Camidge, AT Shaw, S Gadgeel, JS Ahn, DW Kim, SHI Ou, ...
New England Journal of Medicine 377 (9), 829-838, 2017
Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
WTA Van Der Graaf, JY Blay, SP Chawla, DW Kim, B Bui-Nguyen, ...
The Lancet 379 (9829), 1879-1886, 2012
Adjuvant nivolumab versus ipilimumab in resected stage III or IV melanoma
J Weber, M Mandala, M Del Vecchio, HJ Gogas, AM Arance, CL Cowey, ...
New England Journal of Medicine 377 (19), 1824-1835, 2017
Brentuximab vedotin with chemotherapy for stage III or IV Hodgkin’s lymphoma
JM Connors, W Jurczak, DJ Straus, SM Ansell, WS Kim, A Gallamini, ...
New England Journal of Medicine 378 (4), 331-344, 2018
Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study
MC Garassino, BC Cho, JH Kim, J Mazières, J Vansteenkiste, H Lena, ...
The Lancet Oncology 19 (4), 521-536, 2018
Effect of supplementation of Bacillus subtilis LS 1-2 to broiler diets on growth performance, nutrient retention, caecal microbiology and small intestinal morphology
S Sen, SL Ingale, YW Kim, JS Kim, KH Kim, JD Lohakare, EK Kim, HS Kim, ...
Research in Veterinary Science 93 (1), 264-268, 2012
Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the …
B Keam, SA Im, HJ Kim, DY Oh, JH Kim, SH Lee, EK Chie, W Han, ...
BMC cancer 7, 1-11, 2007
Pooled analysis of CNS response to alectinib in two studies of pretreated patients with ALK-positive non–small-cell lung cancer
SM Gadgeel, AT Shaw, R Govindan, L Gandhi, MA Socinski, DR Camidge, ...
Journal of Clinical Oncology 34 (34), 4079, 2016
Clinical heterogeneity of extranodal NK/T-cell lymphoma, nasal type: a national survey of the Korean Cancer Study Group
TM Kim, SY Lee, YK Jeon, BY Ryoo, GJ Cho, YS Hong, HJ Kim, SY Kim, ...
Annals of Oncology 19 (8), 1477-1484, 2008
Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: phase III randomized LUX-Lung 5 trial
M Schuler, JCH Yang, K Park, JH Kim, J Bennouna, YM Chen, C Chouaid, ...
Annals of Oncology 27 (3), 417-423, 2016
Second-line chemotherapy versus supportive cancer treatment in advanced gastric cancer: a meta-analysis
HS Kim, HJ Kim, SY Kim, TY Kim, KW Lee, SK Baek, MH Ryu, BH Nam, ...
Annals of Oncology 24 (11), 2850-2854, 2013
Harpoon: a flow-level traffic generator for router and network tests
J Sommers, H Kim, P Barford
ACM SIGMETRICS Performance Evaluation Review 32 (1), 392-392, 2004
Exposure to volatile organic compounds and loss of pulmonary function in the elderly
HI Yoon, YC Hong, SH Cho, H Kim, YH Kim, JR Sohn, M Kwon, SH Park, ...
European respiratory journal 36 (6), 1270-1276, 2010
Characterization of large structural genetic mosaicism in human autosomes
MJ Machiela, W Zhou, JN Sampson, MC Dean, KB Jacobs, A Black, ...
The American Journal of Human Genetics 96 (3), 487-497, 2015
Search for the direct production of charginos and neutralinos in final states with tau leptons in pp collisions with the ATLAS detector
M Aaboud, G Aad, B Abbott, O Abdinov, B Abeloos, SH Abidi, ...
The European Physical Journal C 78, 1-33, 2018
Resveratrol inhibits inducible nitric oxide synthase and cyclooxygenase-2 expression in β-amyloid-treated C6 glioma cells
Y Kim, SY Lim, SH Rhee, KY Park, CH Kim, BT Choi, SJ Lee, YM Park, ...
International journal of molecular medicine 17 (6), 1069-1075, 2006
INDUCTWISE: Inductance-wise interconnect simulator and extractor
TH Chen, C Luk, H Kim, CCP Chen
Proceedings of the 2002 IEEE/ACM international conference on Computer-aided …, 2002
The system can't perform the operation now. Try again later.
Articles 1–20